tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tandem Diabetes price target raised to $16 from $14 at Goldman Sachs
PremiumThe FlyTandem Diabetes price target raised to $16 from $14 at Goldman Sachs
22d ago
Tandem Diabetes price target raised to $18 from $16 at Mizuho
Premium
The Fly
Tandem Diabetes price target raised to $18 from $16 at Mizuho
22d ago
Tandem Diabetes Care: Strong Buy Rating Backed by Strategic Growth Initiatives and Attractive Valuation
Premium
Ratings
Tandem Diabetes Care: Strong Buy Rating Backed by Strategic Growth Initiatives and Attractive Valuation
22d ago
Tandem Diabetes reports Q3 EPS (31c), consensus (34c)
PremiumThe FlyTandem Diabetes reports Q3 EPS (31c), consensus (34c)
22d ago
Tandem Diabetes affirms FY25 revenue view of $1.0B, consensus $1.0B
Premium
The Fly
Tandem Diabetes affirms FY25 revenue view of $1.0B, consensus $1.0B
22d ago
TNDM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
TNDM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
25d ago
Tandem Diabetes announces t:slim X2 insulin pump cleared for use in U.S.
PremiumThe FlyTandem Diabetes announces t:slim X2 insulin pump cleared for use in U.S.
2M ago
Leerink says removal of C-peptide requirement would benefit pump market, Tandem
Premium
The Fly
Leerink says removal of C-peptide requirement would benefit pump market, Tandem
2M ago
Tandem Diabetes announces publication of 2IQP study in Diabetes Care
Premium
The Fly
Tandem Diabetes announces publication of 2IQP study in Diabetes Care
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100